Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A

Vaccine

Volumn 25, Issue 33, 2007, Pages 6201-6210

  Zhang, Ping ^a   Lewis, Janina P ^b   Michalek, Suzanne M ^c   Katz, Jannet ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Costimulatory molecules; Mucosal adjuvants; Mucosal immunization; Porphyromonas gingivalis gingipain

Indexed keywords

ADHESIN; B7 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN B SUBUNIT; CYSTEINE PROTEINASE; GINGIPAIN KGP; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHORYL LIPID A; RECOMBINANT HEMAGGLUTININ ADHESIN DOMAIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADHESINS, BACTERIAL; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, CD80; ANTIGENS, CD86; CHOLERA TOXIN; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HEMAGGLUTININS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; LIPID A; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PORPHYROMONAS GINGIVALIS;

EID: 34447622861     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.066     Document Type: Article

References (45)

1. Dzink J.L., Socransky S.S., and Haffajee A.D. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 15 (1988) 316-323
2. Lamont R.J., and Jenkinson H.F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 62 (1998) 1244-1263
3. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., and Kent R.L.J. Microbial complexes in subgingival plaque. J Clin Periodontol 25 (1998) 134-144
4. Holt S.C., Kesavalu L., Walker S., and Genco C.A. Virulence factors of Porphyromonas gingivalis. Periodontology 1999 20 (2000) 168-238
5. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 74 (2003) 111-118
6. Kuramitsu H.K. Proteases of Porphyromonas gingivalis: what don't they do?. Oral Microbiol Immunol 13 (1998) 263-270
7. Potempa J., Banbula A., and Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontology 2000 24 (2000) 153-192
8. Barkocy-Gallagher G.A., Han N., Patti J.M., Whitlock J., Progulske-Fox A., and Lantz M. Analysis of the prtP gene encoding porphypain, a cysteine proteinase of Porphyromonas gingivalis. J Bacteriol 178 (1996) 2734-2741
9. Han N., Whitlock J., and Progulske-Fox A. The hemagglutinin gene A (hagA) of Porphyromonas gingivalis 381 contains four large, contiguous, direct repeats. Infect Immun 64 (1996) 4000-4007
10. Kozarov E., Whitlock J., Dong H., Carrasco E., and Progulske-Fox A. The number of direct repeats of hagA is variable among Porphyromonas gingivalis strains. Infect Immun 66 (1998) 4721-4725
11. Pike R.N., McGraw W., Potempa J., and Travis J. Lysine and arginine specific proteinases from Porphyromonas gingivalis. Isolation, characterization and evidence for the existance of complexes with hemagglutinins. J Biol Chem 269 (1994) 406-411
12. Pike R.N., Potempa J., McGraw W., Coetzer T.H.T., and Travis J. Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol 178 (1996) 2876-2882
13. Booth V., Ashley F.P., and Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun 64 (1996) 422-427
14. Curtis M.A., Aduse-Opoku J., Slaney J.M., Rangarajan M., Booth V., Cridland J., et al. Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present in multiple gene products. Infect Immun 64 (1996) 2532-2539
15. Zhang P., Yang Q.-B., Balkovetz D.F., Lewis J.P., Clements J.D., Michalek S.M., et al. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. Vaccine 23 (2005) 4734-4744
16. Azuma M., Yssel H., Phillips J.H., Spits H., and Lanier L.L. Functional expression of B7/BB1 on activated lymphocytes. J Exp Med 177 (1993) 845-850
17. Chambers C.A., and Allison J.P. Costimulation in T cell responses. Curr Opin Immunol 9 (1997) 396-404
18. Linsley P.S., and Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11 (1993) 191-212
19. Martin M., Michalek S.M., and Katz J. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun 71 (2003) 2498-2507
20. Kariv I., Truneh A., and Sweet R.W. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J Immunol 157 (1996) 29-38
21. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., and Peach R. Human B7-1 (CD80) B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1 (1994) 793-801
22. Yang Q.-B., Martin M., Michalek S.M., and Katz J. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis. Infect Immun 70 (2002) 3557-3565
23. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.-Y., Rennert P.D., et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2 (1995) 523-532
24. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 (1995) 707-718
25. Bagenstose L.M., Class R., Salgame P., and Monestier M. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin Exp Immunol 127 (2002) 12-19
26. Lutz M.B., Kukutsch N., Ogilvie A.L.J., Robner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 (1999) 77-92
27. Garcia C.A., Martin M., and Michalek S.M. Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar typhimurium and its cloned antigen. Infect Immun 72 (2004) 5824-5831
28. Martin M., Sharpe A., Clements J.D., and Michalek S.M. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli. J Immunol 169 (2002) 1744-1752
29. Ismaili J., Rennesson J., Aksoy E., Vekemans J., Vincart B., Amraoui Z., et al. Monophosphoryl lipid A activates both human dendrictic cells and T cells. J Immunol 168 (2002) 926-932
30. Wu Z.-Q., Khan A.Q., Shen Y., Schartman J., Peach R., Lees A., et al. B7 requirments for primary and secondary protein-and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol 165 (2000) 6849-6948
31. Thebeau L.G., and Morrison L.A. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation. J Virol 77 (2003) 2426-2435
32. + T cell proliferation after activation with suboptimal doses of PHA. DNA Cell Biol 21 (2002) 137-149
33. Cong Y., Weaver C.T., and Elson C.O. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J Immunol 159 (1997) 5301-5308
34. Boyaka P.N., McGhee J.R., Czerkinsky C., and Mestecky J. Mucosal vaccines: an overview. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology (2005), Elsevier Academic Press, San Diego 855-874
35. Park S., Chun S., and Kim P. Intraperitoneal delivery of cholera toxin B subunit enhances systemic and mucosal antibody responses. Mol Cells 16 (2003) 106-112
36. De Becker G., Moulin V., Pajak B., Bruck C., Francotte M., Thiriart C., et al. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int Immunol 12 (2000) 807-815
37. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6 (1997) 303-313
38. Zhang P., Yang Q.-B., Marciani D.J., Martin M., Clements J.D., Michalek S.M., et al. Effectiveness of the quijalla saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis. Vaccine 21 (2003) 4459-4471
39. Baldridge J.R., Yorgensen Y., Ward J.R., and Ulrich J.T. Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration. Vaccine 18 (2000) 2416-2425
40. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Gorai I., et al. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. Infect Immun 66 (1998) 823-826
41. Myers K., Beining P., Betts M., Snippe H., Inman J., and Golding B. Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice. Infect Immun 63 (1995) 168-174
42. Moore A., McCarthy L., and Mills K.H. The adjuvant combination of monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1. Vaccine 17 (1999) 2517-2527
43. Lanier L.L., O'Fallon S., Somoza C., Phillips J.H., Linsley P.S., Okumura K., et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154 (1995) 97-105
44. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 (1996) 233-258
45. Strober W., Fagarasan S., and Lycke N. IgA B cell development. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology. 3rd ed. (2005), Elsevier Academic Press, San Diego 583-616